CEL-SCI (CVM) News Today → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free CVM Stock Alerts $1.46 +0.05 (+3.55%) (As of 04/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCEL-SCI Appoints Mario Gobbo to Its Board of Directorsbusinesswire.com - April 23 at 9:00 AMCEL-SCI Co. (NYSE:CVM) to Post FY2024 Earnings of ($0.51) Per Share, Zacks Small Cap Forecastsmarketbeat.com - April 17 at 5:39 PMChannel V Media Expands Content Marketing Division; Names Gabriella Bock Director of Contentbusinesswire.com - April 16 at 9:00 AMResearch Analysts Offer Predictions for CEL-SCI Co.'s Q2 2024 Earnings (NYSE:CVM)marketbeat.com - April 16 at 7:27 AMCVM: Parallel Engagement on Four Frontsfinance.yahoo.com - April 15 at 2:05 PMScientists produce in vitro model of cell differentiation during early facial developmentmsn.com - April 12 at 2:47 PMResearchers discover two vesicle fusion mechanisms while studying vesicle movement in living cellsmsn.com - April 9 at 1:35 PMCVM CEL-SCI Corporationseekingalpha.com - April 6 at 12:58 AMCross-species insights: Study finds calcium link in plant and animal immunitymsn.com - March 28 at 1:26 PMCEL-SCI's LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunologystockhouse.com - March 19 at 10:32 AMCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunologyfinance.yahoo.com - March 19 at 10:17 AMResearchers reveal a new mechanism that regulates intestinal stem cellsmsn.com - March 11 at 2:41 PMCEL-SCI Corporation Issues Letter to Shareholdersbusinesswire.com - March 6 at 8:45 AMCVM Apr 2024 4.000 callfinance.yahoo.com - February 23 at 6:43 AMCEL-SCI Co. (NYSE:CVM) Position Reduced by D.A. Davidson & CO.marketbeat.com - February 17 at 6:12 AMCEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Resultsfinance.yahoo.com - February 15 at 8:18 AMCEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Resultsbusinesswire.com - February 15 at 8:00 AMCEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stockfinance.yahoo.com - February 13 at 1:33 PMCel-Sci: Fabulous Story Stock Works To Pass Muster With FDAseekingalpha.com - February 12 at 12:31 PMWhy CEL-SCI Corporation (CVM) Shares Are Divingmsn.com - February 9 at 1:54 PMCEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stockfinance.yahoo.com - February 9 at 10:42 AMCEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drugstockhouse.com - February 6 at 9:26 AMEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path Towards Marketing Authorization for Multikine®stockhouse.com - January 31 at 12:12 PMCVM: Fiscal Year 2023 in Reviewfinance.yahoo.com - January 8 at 9:38 AMCEL-SCI (NYSE:CVM) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPSmarketbeat.com - December 23 at 8:55 AMCEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developmentsfinance.yahoo.com - December 22 at 8:26 AMCEL-SCI Corp CVMmorningstar.com - December 14 at 1:39 PMCVM: NICE To Have Your Supportfinance.yahoo.com - December 8 at 9:27 AMUK'S National Institute for Health and Care Excellence (NICE) Selects CEL-SCI's Multikine as Potential New Standard of Care for Head & Neck Cancerbarrons.com - December 4 at 9:55 PMCEL-SCI Announces Closing of $5 Million Public Offering of Common Stockbenzinga.com - November 20 at 7:46 PMCVM: Target Population Comes Into Relieffinance.yahoo.com - November 8 at 10:18 AMCEL-SCI Corporation: CEL-SCI Issues Letter to Shareholdersfinanznachrichten.de - October 30 at 9:45 AMCEL-SCI Issues Letter to Shareholdersfinance.yahoo.com - October 30 at 9:45 AMCVM, ASTI and SONN among pre-market losersmsn.com - October 25 at 9:43 AMCEL-SCI Releases Video Detailing Recent Phase 3 Findings & its Plans to Seek Immediate Regulatory Approvalsfinance.yahoo.com - October 24 at 8:30 AMCEL-SCI Readies Its Multikine Manufacturing Facility for Commercial Scale Productionstockhouse.com - October 19 at 9:08 AMCVM: Regulatory Journey Acceleratingfinance.yahoo.com - October 9 at 12:27 PMCEL-SCI Files Request With the UK’s MHRA Regarding Path to Approval for Multikine in the Treatment of Head & Neck Cancerfinance.yahoo.com - October 5 at 9:43 AMCEL-SCI Submits Scientific Advice Filing to European Medicines Agency (EMA) for Multikine in the Treatment of Head & Neck Cancerfinance.yahoo.com - September 26 at 9:33 AMCEL-SCI Corporation Reports Third Quarter Fiscal 2023 Financial Resultsfinance.yahoo.com - August 11 at 4:04 PMCVM: Model Revisionsfinance.yahoo.com - July 31 at 10:09 AMCEL-SCI Announces Closing of Public Offeringfinance.yahoo.com - July 20 at 12:44 PMCEL-SCI stock dips on pricing $5 million capital raise via stock offeringmsn.com - July 19 at 10:12 AMCel-Sci (NYSE:CVM) Plummets on $5M Stock Offeringmsn.com - July 18 at 2:40 PMWhy CEL-SCI (CVM) Shares Are Down 20%benzinga.com - July 18 at 1:11 PMCEL-SCI Shares Slide Premarket After Public Offering Priced >CVMmarketwatch.com - July 18 at 8:10 AMCEL-SCI Announces Pricing of Public Offeringfinance.yahoo.com - July 17 at 10:08 PMCEL-SCI Announces Proposed Public Offering of Common Stockbusinesswire.com - July 17 at 5:08 PMCEL-SCI shares tumble on stock offering plansmsn.com - July 17 at 5:08 PMCEL-SCI receives FDA feedback on lead asset Multikineseekingalpha.com - July 14 at 11:42 AM Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet. See how you can invest alongside him CVM Media Mentions By Week CVM Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVM News Sentiment▼0.000.34▲Average Medical News Sentiment CVM News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVM Articles This Week▼01▲CVM Articles Average Week Get CEL-SCI News Delivered to You Automatically Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Curis News Today Protalix BioTherapeutics News Today AlloVir News Today Athira Pharma News Today Atara Biotherapeutics News Today Sangamo Therapeutics News Today Gritstone bio News Today Cognition Therapeutics News Today Genenta Science News Today Passage Bio News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CVM) was last updated on 5/1/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPub#1 election stockPorter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBiden out June 13; Kamala won’t replace him?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRevolutionizing Healthcare: A Biotech Stock You Can't IgnoreBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
